| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |